Skip to content

Clinical trials

Phase 1 Anthrax trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anthrax Phase: Phase 1 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20051
20061
20093
20103
20111
20133
20141
20151
20162
20181
20203
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Elusys Therapeutics3
Emergent BioSolutions3
National Institute of Allergy and Infectious Diseases (NIAID)3
PharmAthene, Inc.3
Altimmune, Inc.2
Centre Hospitalier Universitaire de Saint Etienne2
AstraZeneca1
BlueWillow Biologics1
Bristol-Myers Squibb1
Chiesi Farmaceutici S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anthrax27
Poisoning2
Asthma1
HIV Infections1
Infections1
Pulmonary Disease, Chronic Obstructive1

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.